The skin, our body's largest organ, often gets the short end of the stick when it comes to oxygen allocation. In the body's hierarchy of oxygen distribution, the brain receives the lion's share, around 20-25 per cent, followed by other vital organs. This means that the skin typically receives less oxygen, which can affect its health and healing capabilities. Hyperbaric Oxygenation (HBOT ) can compensate for this by significantly increasing blood oxygen levels. This offers substantial benefits for skin health, particularly through its anti-inflammatory effects.
Inflammation underlies many skin conditions and diseases, and by reducing it, HBOT can alleviate symptoms and enhance healing. A critical advantage of HBOT is its stimulation of new blood vessel formation, or angiogenesis. This is crucial for wound healing, especially in infected wounds, or those at risk of amputation. The increased blood supply delivers essential nutrients and oxygen more efficiently, speeding up the healing process and reducing the risk of severe complications.
For chronic conditions like psoriasis, an autoimmune disease characterised by rapid skin cell turnover, HBOT can significantly relieve symptoms. HBOT boosts the immune system, reduces inflammation, and promotes healthier skin function, providing much-needed relief.
Another area of positive results is for skin conditions associated with menopause. HBOT helps balance these hormones, reducing inflammation and enhancing collagen production and new blood vessel creation. This leads to healthier skin during menopause. This combined with the ability of HBOT to modulate the immune system can make it a very attractive treatment for alleviating menopause related symptoms.
HBOT offers numerous benefits for skin health by addressing the body's oxygen distribution hierarchy. It reduces inflammation, promotes wound healing, balances hormonal changes during menopause, and boosts collagen production, helping your skin look and feel its best.
Contact OxyGeneration on 091-394444 for more information.
